Screening for hereditary pheochromocytoma in a patient with neurofibromatosis type 1: A case report

0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Pheochromocytoma (PHEO) is a rare tumour that arises from adreno-medullary chromaffin cells and secretes catecholamines. These hormones are also secreted by paragangliomas, which derive from extra-adrenal cells of the sympathetic paravertebral ganglia. At least one-third of PHEOs are familial. Neurofibromatosis type 1 (NF1), or von Recklinghausen's disease, is diagnosed upon clinical criteria, and the study of PHEO is advised if hypertension is present. The incidence of PHEO in NF1 is 0.1-5.7% and explains hypertension in 20-50% of these patients. Recent advances in the treatment of this condition and preoperative preparation allow us to reduce its high cardiovascular morbimortality. Here we present the case of a 31-year-old female with known NF1 who presented with 5 months' history of non-specific symptoms and an episode of intraoperative hypertensive crisis. The workup detected a left sided PHEO, which was treated surgically. Our case illustrates the high prevalence of hereditary PHEO and how its presentation can go unnoticed. It reinforces the significance of screening for PHEO in patients with NF1.

Cite

CITATION STYLE

APA

Barros, I. I. F., Manso, F., Caldas e Silva, A. I., & Pereira, M. R. S. L. (2021). Screening for hereditary pheochromocytoma in a patient with neurofibromatosis type 1: A case report. TouchREVIEWS in Endocrinology, 17(1), 79–82. https://doi.org/10.17925/EE.2021.1.1.79

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free